• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

The Impact of Opioids on the Endocrine and Immune Systems

Slideshow

How much do you know about the impact of opioids on the endocrine and immune systems? Take our 9-question quiz to find out. 

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Ruxolitinib Cream Demonstrates Long-Term Safety and Disease Control in Young Patients With Atopic Dermatitis

Ruxolitinib Cream Demonstrates Long-Term Safety and Disease Control in Young Patients With Atopic Dermatitis

Grace Halsey
June 6th 2025
Article

RAD 2025: In the TRuE-AD3 study, participants aged 2-6 and 7-11 years spent nearly half of the long-term treatment period free of medication.

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Sydney Jennings
June 4th 2025
Podcast

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

Dupilumab Sustains Long-Term Reduction of Staphylococcus aureus in Patients with Atopic Dermatitis

Dupilumab Sustains Long-Term Reduction of Staphylococcus aureus in Patients with Atopic Dermatitis

Sydney Jennings
June 6th 2025
Article

RAD 2025: Researchers observed a marked reduction and low burden of viable S. aureus on lesional and non-lesional skin after 1 year of dupilumab treatment.

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care

Sydney Jennings;Elizabeth Mollard, PhD
May 22nd 2025
Podcast

At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.

Lebrikizumab Maintains Deep Response, QoL Through 3 Years in Atopic Dermatitis Extension Study

Lebrikizumab Maintains Deep Response, QoL Through 3 Years in Atopic Dermatitis Extension Study

Sydney Jennings
June 6th 2025
Article

RAD 2025: Under lebrikizumab maintenance treatment in week 16 responders, approximately 8 out of 10 achieved almost clear skin up to 3 years.

Safety and Local Tolerability of Roflumilast Cream 0.15% in Patients With Atopic Dermatitis and Prior Topical Treatment Limitations /image credit Oregon Health and Science University

Roflumilast Cream 0.15% Demonstrates Safety, Tolerability in Individuals With Atopic Dermatitis With Prior Treatment Failures

Grace Halsey
June 6th 2025
Article

RAD 2025: Safety and tolerability of roflumilast cream 0.15% was demonstrated in a pooled subgroup analysis of phase 3 study participants unresponsive to or intolerant of previous topical therapy.

© 2025 MJH Life Sciences

All rights reserved.